Geode Capital Management’s Scopus BioPharma Inc. Common Stock SCPS Stock Holding History

Geode Capital Management’s Portfolio SCPS Stock Details SCPS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-217,078	Closed	-$52K	–	4989
2022 Q3	$52K	Hold	217,078	–	–	﹤0.01%	4759
2022 Q2	$93K	Buy	217,078 +13,273	+7%	+$6.38K	﹤0.01%	4622
2022 Q1	$140K	Buy	203,805 +137,684	+208%	+$133K	﹤0.01%	4532
2021 Q4	$108K	Buy	+66,121	New	+$200K	﹤0.01%	4706
2021 Q2	–	Sell	-52,159	Closed	-$440K	–	4741
2021 Q1	$440K	Buy	+52,159	New	+$546K	﹤0.01%	3854

Other funds holding SCPS

MRCM

M&R Capital Management Summit, New Jersey $454M AUM 40.11% 1-Year Est. Return

Geode Capital Management's SCPS Position: Q4 2022 in Review

Geode Capital Management sold out of Scopus BioPharma Inc. Common Stock (SCPS) in Q4 2022, closing a stake of 217,078 shares — an estimated $52K sold.

Geode Capital Management first reported a position in SCPS in Q1 2021 and held it in 5 quarters. The position peaked at $440K in Q1 2021. 1 fund tracked by Wall St. Rank holds SCPS as of Q4 2022.

Geode Capital Management reported no remaining Scopus BioPharma Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Geode Capital Management sold 217,078 Scopus BioPharma Inc. Common Stock shares in Q4 2022, an estimated $52K.
Geode Capital Management first reported a position in Scopus BioPharma Inc. Common Stock in Q1 2021 and held it in 5 quarters.
Geode Capital Management's Scopus BioPharma Inc. Common Stock position peaked at $440K in Q1 2021.
1 fund tracked by Wall St. Rank held Scopus BioPharma Inc. Common Stock as of Q4 2022.

Based on Geode Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.